1. Home
  2. PBHC vs PMN Comparison

PBHC vs PMN Comparison

Compare PBHC & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pathfinder Bancorp Inc. (MD)

PBHC

Pathfinder Bancorp Inc. (MD)

HOLD

Current Price

$16.26

Market Cap

99.8M

Sector

Finance

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$15.70

Market Cap

115.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBHC
PMN
Founded
1859
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Banks
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
99.8M
115.5M
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
PBHC
PMN
Price
$16.26
$15.70
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$42.67
AVG Volume (30 Days)
22.6K
55.9K
Earning Date
04-29-2026
05-13-2026
Dividend Yield
2.94%
N/A
EPS Growth
46.25
N/A
EPS
0.47
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$34.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.06
$0.29
52 Week High
$17.40
$27.40

Technical Indicators

Market Signals
Indicator
PBHC
PMN
Relative Strength Index (RSI) 58.08 67.94
Support Level $13.74 $8.79
Resistance Level $17.17 $19.85
Average True Range (ATR) 0.78 1.30
MACD -0.07 0.15
Stochastic Oscillator 50.31 90.79

Price Performance

Historical Comparison
PBHC
PMN

About PBHC Pathfinder Bancorp Inc. (MD)

Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: